No Data
Special treat Guandian (688287.SH) received a regulatory letter from the Shanghai Stock Exchange regarding the company's factoring business.
ST Special Treat (688287.SH) announcement, the company received a notice from the Shanghai Stock Exchange on November 18, 2024...
Guandian Defense (688287.SH) stocks will be subject to other risk warnings.
Announcement from Guandian Defense (688287.SH), the company found in self-inspection that, as of May 29, 2024, the actual controlling...
October 29th A-share investment lightning rod │ West Point Pharmaceutical: Shareholders Guotou High-Tech and Hangzhou Chuanghe plan to collectively reduce their shareholding by no more than 3%.
West Point Pharmaceuticals shareholders Guotou High-Tech and Hangzhou Chuanghe plan to collectively reduce their holdings by no more than 3%; Zhejiang Talent Television and Film shareholder Dongyang Juwen plans to reduce their holdings by no more than 2%; Hualv Biotechnology shareholder Gaotou Development plans to reduce their holdings by no more than 5.36%; Haoyuan Medicine shareholders Suxin Fund and Zhenjin Investment plan to collectively reduce their holdings by no more than 3.34%; Zhengzhou Tiamaes Technology incurred a net loss of 52.8719 million yuan in the first three quarters; Guandian Defense stocks may be subject to other risk warnings; China Design Group stated that director Liu Peng received a notice of filing.
Gudian Defense: Third Quarter Report 2024
Third Quarter Report 2024
Guandian Defense (688287.SH) released its performance for the first three quarters, with a net loss of 60.81 million yuan.
GuanDian Defense (688287.SH) disclosed the third quarter report for 2024, with the company achieving revenue of 74...
